1. Riedel S, Hobden JA, Miller S, Morse SA, Mietzner TA, Detrick B, et al. Jawetz melnick adelbergs medical microbiology. 28th ed. Mcgraw Hill Publication. 2007; P.231-6. 2. Khardori N. Anthrax bacteriology clinical presentations and management in khardori bioterrorism preparedness medicine public health policy. Wiley VCH Verlag GmbH Weinheim Publication.2006; P. 123-45. 3. Gonzalez MR, Bischofberger M, Pernot L, Goot FG, Freche B. Bacterial poreforming toxins the hole story. Cell Mol Life Sci 2008; 65:493-507 4. Edwards KA, Clancy HA, Baeumner AJ. Bacillus anthracis toxicology, epidemiology and current rapid detection methods. Anal Bioanal Chem2006;384:73-84. doi.10.1007/s00216-005-0090-x. 5. Gupta P, Waheed SM, Bhatnagar R. Expression and purification of the recombinant protective antigen of Bacillus anthracis. Prote Exp Pur 1999; 16:369-76. doi.10.1006/prep.1999.1066. 6. Wang, JY, Roehrl, MH. Anthrax vaccine design: strategies to achieve comprehensive protection against spore Bacillus and toxin. Med Immunol2005; 24: 4:4. doi.10.1186/1476-9433-4-4 7. Hepburn MJ, Hugh Dyson E, Simpson AJ, Brenneman KE, Bailey N, Wilkinson L, Hornby R, Mateczun AJ, Bell MG, Baillie LW. Immune response to two different dosing schedules of the anthrax vaccine precipitated vaccine. Vaccine2007; 25:6089-97. doi.10.1016/j.vaccine.2007.05.018. 8. Chi X, Li J, Liu W, Wang X, Yin K, Liu J, Zhang X. Generation and characterization of human monoclonal antibodies targeting anthrax protective antigen following vaccination with a recombinant protective antigen vaccine. Clin Vac Immunol 2015; 22: 553-60. doi.10.1128/CVI.00792-14 9. Williamson D, Dyson EH. Anthrax prophylaxis recent advances and future directions. Front Microbiol2015; 6, 1009. doi.10.3389/fmicb.2015.01009 10. Knockenhauer KE, Sawicka KM, Roemer EJ, Simon SR. Protective antigen composite nanofibers as a transdermal anthrax vaccine. Con Proc IEEE Eng Med Biol Soc2008;5: 1040-3. doi. 10.1109/IEMBS.2008.4649337 11. Blum JS, Saltzman WM. High loading efficiency and tunable release of plasmid DNA encapsulated in submicron particles fabricated from Plga conjugated with poly L lysine]. J Cont Rel 2008;129:66-72. doi.10.1016/j.jconrel.2008.04.002 12. Ghasemi R, Abdollahi M, Zadeh EE, Khodabakhshi K, Badeli A, Bagheri H, et al. Mpeg-pla and pla-peg-pla nanoparticles as new carriers for delivery of recombinant human growth hormone. Sci Rep2018;8:9854. doi.10.1038/s41598-018-28092-8 13. Etemadaubi M, Honari H, Hajinourmohamadi A, Bagheri H, Noofeli M. [Assessment of cytotoxicity of Bacillus anthracis recombinant protective antigen in free and encapsulated forms by double block Pla-peg and Pcl-peg copolymers on vero cell]. Jundishapur Sci Med J 2018; 17:377-86. (Persian) 14. Singh NA, Mandal AKA, Khan ZA. Fabrication of Pla-peg nanoparticles as delivery systems for improved stability and controlled release of catechin. J Nanomate 2017; :1-9. doi. 10.1155/2017/6907149 15. Kim SK, Foote MB, Huang L. The targeted intracellular delivery of cytochrome C protein to tumors using lipid apolipoprotein nanoparticles]. Biomaterials2012;33:3959-66. doi. 10.1016/j.biomaterials.2012.02.010 16. Park J, Wrzesinski SH, Stern E, Look M, Criscione J, Ragheb R, et al. Combination delivery of TGFβ inhibitor and IL2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy. Nat Mate 2012;11:895-905. doi.10.1038/nmat3355 17. Manickavasagam D, Novak K, Oyewumi MO. Therapeutic delivery of simvastatin loaded in Pla-peg polymersomes resulted in amplification of anti inflammatory effects in activated microglia. AAPS J2017;20:18. doi.10.1208/s12248-017-0176-3 18. Vila A, Gill H, Mccallion O, Alonso MJ. Transport of Pla-peg particles across the nasal mucosa effect of particle size and peg coating density]. J Cont Rel2004;98:231-44. doi.10.1016/j.jconrel.2004.04.026 19. Manish M, Rahi A, Kaur M, Bhatnagar R, Singh S. A single dose Plga encapsulated protective antigen domain 4 nanoformulation protects Mice against Bacillus anthracis spore challenge. Plos One 2013;8:61885. doi.10.1371/journal.pone.0061885 20. Malik A, Gupta M, Mani R, Gogoi H, Bhatnagar R. Trimethyl chitosan nanoparticles encapsulated Protective antigen protects the Mice against anthrax. Front Immunol. 2018;9:562. doi. 10.3389/fimmu.2018.00562 21. Jain AK, Goyal AK, Mishra N, Vaidya B, Mangal S, Vyas SP. Peg-pla–peg block copolymeric nanoparticles for oral immunization against hepatitis B. Int J Pharm 2010;387:253-62. doi.10.1016/j.ijpharm.2009.12.013 22. Dong Y, Feng SS. Nanoparticles of poly D L‐lactide methoxy poly ethylene glycol poly D L lactide blends for controlled release of paclitaxel. J Biomed Mate Res2006;78:9-12. doi. 10.1002/jbm.a.30684 23. Li M, Cai RJ, Song S, Jiang ZY, Li Y, Gou HC, Qiu HJ. Evaluation of immunogenicity and protective efficacy of recombinant outer membrane proteins of Haemophilus parasuis serovar 5 in a murine model. PLos One 2017;12:176537. doi.10.1371/journal.pone.0176537 24. Martins VT, Chavezfumagalli MA, Lage DP, Duarte MC, Garde E, Costa LE. et al. Antigenicity immunogenicity and protective efficacy of three proteins expressed in the promastigote and amastigote stages of Leishmania infantum against visceral Leishmaniasis. PLos One2015;10:137683. doi. 10.1371/journal.pone.0137683
|